 "AstraZeneca")
AstraZeneca Pharma India on Wednesday said its net profit declined by 27 per cent on-year to Rs 38 crore in the second quarter ended on September 30, 2024.
The drug firm reported a net profit of Rs 52 crore in the July-September quarter of last fiscal.
Revenue from operations stood at Rs 408 crore for the period under review compared with Rs 311 crore in the year-ago period, the firm said in a regulatory filing.
Shares of the company ended 3.74 per cent lower at Rs 7,133.10 apiece on the BSE.
 "Q2 earnings, Q2 result")
 "Q2 earnings, Q2")
 "Just a day ahead of the hurriedly called Vodafone Idea (Vi) meeting meant to soothe the nerves of investors amid the company's sliding stock price and a negative narrative around it, the telco announced a $3.6-billion (Rs 30,000 crore) deal with glob")
 "result, q1, q2, q3, q4")
 "Q2 earnings, Q2")
